Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 14
Phase 25

Trial Status

Completed9
Terminated4

Role Distribution

Principal Investigator4
Other Roles9
PI Rate31%

Activity Timeline

Clinical Trials (13)

NCT00670917Not ApplicableCompleted
Magnetic Acupressure in Reducing Pain in Cancer Patients Undergoing Bone Marrow Aspiration and Biopsy
Hematopoietic/Lymphoid CancerPain
PrincipalinvestigatorStart date: 2008-05-07
NCT00471653Terminated
Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy
Brain and Central Nervous System TumorsThrombocytopenia
StudychairStart date: 2006-11-11
NCT00401024Phase 1Completed
Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma
Brain and Central Nervous System Tumors
StudychairStart date: 2006-10-12
NCT00082797Phase 2Completed
High-Dose Methotrexate and Leucovorin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Brain and Central Nervous System Tumors
StudychairStart date: 2005-07-12
NCT00004004Phase 1/2Completed
Procarbazine in Treating Patients With Recurrent Brain Tumor
Brain and Central Nervous System Tumors
Studychair
NCT00014521Phase 1Completed
Karenitecin in Treating Patients With Recurrent Malignant Glioma
Brain and Central Nervous System Tumors
Studychair

Showing 10 of 13 trials

Research Network

Collaboration Network

9 collaborators·9 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jana Portnow, MD

City of Hope Medical Center

Moderately Similar
7 trials

Shared therapeutic areas:

Brain and Central Nervous System TumorsLymphomaUnspecified Adult Solid Tumor, Protocol Specific

Worked with same sponsors:

Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)
Collaborated on 1 trial
Similarity Score34%

Larry Kleinberg, MD

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Related
6 trials

Shared therapeutic areas:

Brain and Central Nervous System TumorsThromboembolism

Worked with same sponsors:

Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)+2 more
Collaborated on 1 trial
Similarity Score24%

Michael B. Streiff, MD

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Related
1 trials

Shared therapeutic areas:

Brain and Central Nervous System TumorsThromboembolism

Worked with same sponsors:

National Cancer Institute (NCI)North American Brain Tumor Consortium+1 more
Collaborated on 1 trial
Similarity Score24%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

LeukemiaMyelodysplastic SyndromesChronic Myeloproliferative Disorders+6 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score17%

Kyle Weaver, MD

Vanderbilt-Ingram Cancer Center

Related
1 trials

Shared therapeutic areas:

High Grade Glioma

Worked with same sponsors:

National Cancer Institute (NCI)North American Brain Tumor Consortium+1 more
Collaborated on 1 trial
Similarity Score14%

Tanya Trippett, MD

Memorial Sloan Kettering Cancer Center

Related
13 trials

Shared therapeutic areas:

LymphomaLeukemiaLymphoproliferative Disorders

Worked with same sponsors:

National Cancer Institute (NCI)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Similarity Score6%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

LymphomaMyelodysplastic Syndromes

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Anjali Advani, MD

The Cleveland Clinic

Related
7 trials

Shared therapeutic areas:

LeukemiaLymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Aminah Jatoi, MD

Mayo Clinic

Related
29 trials

Shared therapeutic areas:

Unspecified Adult Solid Tumor, Protocol SpecificPain

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Guillermo Garcia-Manero, MD

M.D. Anderson Cancer Center

Related
18 trials

Shared therapeutic areas:

LeukemiaMyelodysplastic Syndromes
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (13)

Showing 13 of 13 trials

NCT00670917Not ApplicablePrincipalInvestigator

Magnetic Acupressure in Reducing Pain in Cancer Patients Undergoing Bone Marrow Aspiration and Biopsy

Hematopoietic/Lymphoid CancerPain
Completed
NCT00471653StudyChair

Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy

Brain and Central Nervous System TumorsThrombocytopenia
Terminated
NCT00401024Phase 1StudyChair

Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma

Brain and Central Nervous System Tumors
Completed
NCT00082797Phase 2StudyChair

High-Dose Methotrexate and Leucovorin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Brain and Central Nervous System Tumors
Completed
NCT00238277Phase 2PrincipalInvestigator

Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma Multiforme

Brain and Central Nervous System Tumors
Terminated
NCT00004004Phase 1/2StudyChair

Procarbazine in Treating Patients With Recurrent Brain Tumor

Brain and Central Nervous System Tumors
Completed
NCT00014521Phase 1StudyChair

Karenitecin in Treating Patients With Recurrent Malignant Glioma

Brain and Central Nervous System Tumors
Completed
NCT00068770Phase 2StudyChair

Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RT

Brain and Central Nervous System Tumors
Terminated
NCT00253669PrincipalInvestigator

Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas

Brain and Central Nervous System TumorsThromboembolism
Completed
NCT00404248Phase 1/2StudyChair

Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma

Brain and Central Nervous System Tumors
Completed
NCT00897611Not ApplicableStudyChair

Tumor DNA and MRI/CT Scan Findings in Patients With Grade III or Grade IV Malignant Glioma

High Grade Glioma
Completed
NCT00899951PrincipalInvestigator

Studying Fentanyl in Patients With Cancer

Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
Terminated
NCT00999622StudyChair

Study of Blood Samples and Risk of Infection in Patients With Newly Diagnosed Malignant Supratentorial Astrocytoma

Brain and Central Nervous System TumorsInfection
Completed

All 13 trials loaded